HealthEquity, Inc. HQY R2K
Healthcare · Health Information Services · United States
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
READ MORE ›$87.99
-12.54% 1Y
Market & Price
Market Cap
$7.38B
Current Price
$87.99
High / Low (52W)
$113.06 / $73.21
Beta
0.19
Valuation
Stock P/E
32.96
Industry PE
23.65
Forward P/E
16.08
PEG Ratio
1.31
Book Value
$24.79
Price to Book
3.55
P/S
5.52
EV/EBITDA
16.11
Dividend Yield
-
Profitability & Returns
ROCE
10.38%
ROE
11.06%
ROA
6.46%
Profit Margin
17.25%
Op Margin
29.34%
EPS (Latest Qtr)
$0.82
EPS (TTM)
$2.67
Balance Sheet & Liquidity
Debt/Equity
0.48
Quick Ratio
2.85
Current Ratio
3.44
Debt
$984.68M
Total Assets
$3.38B
Current Assets
$512.28M
Working Capital
$355.43M
Ownership
Promoter Holding
2.16%
Chg in Prom Hold
-
FII / Inst Holding
107.09%
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
$8.08B
Total Revenue (TTM)
$1.34B
EBITDA
$501.32M
Free Cash Flow
$370.33M
Operating Cash Flow
$489.88M
Shares Outstanding
83.83M
Gross Margin
70.68%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
15.08%
Profit 5Y
307.72%
Revenue (YoY)
7.20%
Earnings (YoY)
34.40%
PROS
- Compounding revenue at 15.1% over 5 years.
- Profit CAGR of 307.7% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HQY HealthEquity, Inc. R2K | 87.99 | 32.96 | $7.38B | - | 10.38% | 11.06% | 15.08% | 307.72% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Apr 2016 | Jul 2016 | Oct 2016 | Jan 2017 | Apr 2017 | Jul 2017 | Oct 2017 | Jan 2018 | Apr 2018 | Jul 2018 | Oct 2018 | Jan 2019 | Apr 2019 | Jul 2019 | Oct 2019 | Jan 2020 | Apr 2020 | Jul 2020 | Oct 2020 | Apr 2021 | Jul 2021 | Oct 2021 | Jan 2022 | Apr 2022 | Jul 2022 | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 55.42M | 56.88M | 56.79M | 60.44M | 69.90M | 71.07M | 70.50M | 75.78M | 87.05M | 86.62M | 157.12M | 201.20M | 190.01M | 176.04M | 179.35M | 184.20M | 189.10M | 179.95M | 203.30M | 205.68M | 206.14M | 216.09M | 233.84M | 244.43M | 243.55M | 249.22M | 262.39M | 287.60M | 299.93M | - | - | 330.84M | 325.83M | 322.16M | 334.59M | 354.64M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 106.53M | 93.24M | 94.10M | 106.44M | 98.33M |
| Gross Profit | 27.68M | 28.55M | 25.89M | 24.23M | 33.74M | 35.80M | 33.73M | 31.65M | 44.36M | 46.58M | 45.82M | 44.45M | 57.75M | 58.44M | 96.03M | 113.68M | 108.07M | 101.78M | 104.56M | 103.35M | 112.23M | 103.57M | 105.61M | 111.60M | 118.25M | 127.32M | 134.77M | 148.47M | 151.66M | 159.18M | 163.32M | 187.14M | 204.05M | - | - | 224.31M | 232.59M | 228.06M | 228.15M | 256.31M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 139.96M | 141.72M | 148.21M | 155.75M | 152.25M |
| Operating Income | 13.25M | 12.74M | 9.04M | - | 15.93M | 16.50M | 13.56M | - | 20.54M | 21.56M | 18.99M | - | 27.68M | 24.86M | 9.92M | - | 15.07M | 9.03M | 11.50M | 4.25M | -875.00K | -366.00K | - | -7.29M | -2.41M | 5.54M | - | 23.18M | 24.74M | 30.89M | - | 41.63M | 58.93M | - | - | 84.35M | 90.88M | 79.85M | 72.39M | 104.07M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 124.55M | 131.46M | 120.36M | 112.85M | 143.22M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.86M | 14.96M | 14.05M | 13.27M | 12.59M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 70.95M | 78.05M | 67.53M | 60.90M | 92.41M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.04M | 18.19M | 15.84M | 11.16M | 23.00M |
| Net Income | 8.07M | 8.23M | 6.01M | 4.06M | 14.03M | 16.95M | 10.48M | 5.91M | 22.58M | 22.52M | 15.69M | 13.12M | 41.82M | 19.37M | -21.33M | -190.00K | 1.83M | -148.00K | 1.79M | -2.62M | -3.82M | -5.04M | -32.82M | -13.64M | -10.65M | -1.64M | -209.00K | 4.09M | 10.58M | 14.67M | 26.36M | 28.81M | 35.82M | - | - | 53.91M | 59.85M | 51.69M | 49.74M | 69.42M |
| Diluted EPS | 0.14 | 0.14 | 0.10 | 0.07 | 0.23 | 0.27 | 0.17 | 0.09 | 0.36 | 0.36 | 0.25 | 0.21 | 0.65 | 0.30 | -0.30 | 0.00 | 0.03 | 0.00 | 0.02 | -0.03 | -0.05 | -0.06 | - | -0.16 | -0.13 | -0.02 | - | 0.05 | 0.12 | 0.17 | - | 0.33 | 0.40 | - | - | 0.61 | 0.68 | 0.59 | 0.58 | 0.82 |
| R&D Expense | 4.62M | 4.99M | 6.21M | - | 6.24M | 6.80M | 6.87M | - | 7.98M | 8.40M | 8.68M | - | 10.90M | 11.64M | 23.51M | - | 31.08M | 30.65M | 30.76M | 35.47M | 37.90M | 38.07M | - | 45.18M | 46.58M | 48.89M | - | 53.19M | 54.77M | 55.61M | - | 56.09M | 58.58M | 60.19M | - | 61.44M | 64.80M | 65.92M | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 178.37M | 229.53M | 287.24M | 531.99M | 733.57M | - | 861.75M | 999.59M | 1.20B | 1.31B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | 369.81M | 376.95M | 422.51M | 400.31M |
| Gross Profit | 24.12M | 32.80M | 47.97M | 72.60M | 106.36M | 134.92M | 181.19M | 325.91M | 415.33M | - | 491.94M | 622.64M | 777.26M | 913.12M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | 454.28M | 494.50M | 574.39M | 585.64M |
| Operating Income | 7.09M | 11.52M | 16.87M | 26.14M | 41.21M | 54.42M | 77.67M | 77.01M | 34.01M | - | 37.65M | 128.13M | 202.87M | 327.48M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | 171.53M | 283.57M | 339.12M | 489.22M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | 48.42M | 55.45M | 60.63M | 57.13M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | -38.10M | 75.04M | 116.03M | 277.43M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | -11.95M | 19.33M | 19.33M | 62.23M |
| Net Income | 11.17M | 1.23M | 10.17M | 16.61M | 26.38M | 47.36M | 73.90M | 39.66M | 8.83M | - | -26.14M | 55.71M | 96.70M | 215.20M |
| Diluted EPS | 0.25 | -1.26 | 0.21 | 0.28 | 0.44 | 0.77 | 1.17 | 0.58 | 0.12 | - | -0.31 | 0.64 | 1.09 | 2.46 |
| R&D Expense | 4.23M | 7.14M | 10.50M | 16.83M | 22.38M | 27.39M | 35.06M | 77.58M | 124.81M | 157.36M | 193.38M | 218.81M | 239.51M | 262.51M |
Compounded Sales Growth
| 5 Years: | 15.08% |
| 1 Year: | 7.20% |
Compounded Profit Growth
| 5 Years: | 307.72% |
| 1 Year: | 34.40% |
Stock Price Performance
| 1 Year: | -12.54% |
| 6 Months: | -16.55% |
| 3 Months: | +15.03% |
| 1 Month: | +7.99% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jan 2012 | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 55.09M | 158.77M | 219.79M | 279.14M | 369.16M | 510.02M | 2.56B | 2.71B | - | 3.09B | 3.16B | 3.45B | 3.38B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | 382.89M | 557.44M | 477.75M | 512.28M |
| Cash & Equivalents | 5.13M | 5.91M | 13.92M | 111.00M | 83.64M | 139.95M | 199.47M | 361.48M | 191.73M | 328.80M | - | 254.27M | 403.98M | 295.95M | 318.93M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | 96.83M | 104.89M | 118.01M | 123.70M |
| Total Liabilities | - | - | 21.08M | 14.67M | 16.34M | 17.20M | 22.89M | 32.94M | 1.53B | 1.33B | - | 1.19B | 1.13B | 1.33B | 1.27B |
| Current Liabilities | - | - | 9.43M | 8.83M | 12.11M | 15.70M | 20.49M | 29.05M | 151.94M | 204.70M | - | 131.06M | 117.09M | 156.32M | 156.85M |
| Long Term Debt | - | - | - | - | - | - | - | 0 | 1.18B | 924.22M | - | 907.84M | 874.97M | 1.06B | 957.38M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | 994.49M | 933.14M | 1.11B | 1.00B |
| Total Equity | -16.58M | -6.40M | -12.71M | 144.09M | 203.46M | 261.94M | 346.27M | 477.08M | 1.03B | 1.38B | - | 1.90B | 2.04B | 2.11B | 2.11B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 84.76M | 86.13M | 86.54M | 85.01M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.77M | 18.02M | 15.05M | 26.54M | 45.59M | 81.70M | 113.42M | 105.01M | 181.62M | - | 150.65M | 242.83M | 339.86M | 457.09M |
| Investing Cash Flow | -3.54M | -4.64M | -8.44M | -90.55M | -13.05M | -36.75M | 25.65M | -1.74B | -96.96M | - | -119.13M | -46.07M | -505.45M | -47.14M |
| Financing Cash Flow | -7.46M | -5.36M | 90.48M | 36.65M | 23.78M | 14.56M | 22.93M | 1.47B | 52.42M | - | -2.67M | -47.04M | 57.57M | -386.98M |
| Capital Expenditure | -831.00K | -1.59M | -1.71M | -2.38M | -3.65M | -5.46M | -3.87M | -7.29M | -13.09M | - | -119.13M | -46.07M | -505.45M | -48.78M |
| Free Cash Flow | 10.94M | 16.42M | 13.33M | 24.16M | 41.95M | 76.24M | 109.55M | 97.72M | 168.53M | - | 31.52M | 196.75M | -165.60M | 408.32M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | 28.85M | 149.71M | -108.03M | 22.98M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 121.49M | 299.25M |
| Dividends Paid | 0 | 694.00K | 50.35M | 0 | 0 | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jan 2013 | Jan 2014 | Jan 2015 | Jan 2016 | Jan 2017 | Jan 2018 | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | 59.6% | 58.8% | 63.1% | 61.3% | 56.6% | - | 57.1% | 62.3% | 64.8% | 69.5% |
| Operating Margin % | - | - | - | - | 23.1% | 23.7% | 27.0% | 14.5% | 4.6% | - | 4.4% | 12.8% | 16.9% | 24.9% |
| Net Margin % | - | - | - | - | 14.8% | 20.6% | 25.7% | 7.5% | 1.2% | - | -3.0% | 5.6% | 8.1% | 16.4% |
| ROE % | -174.5% | -9.7% | 7.1% | 8.2% | 10.1% | 13.7% | 15.5% | 3.8% | 0.6% | - | -1.4% | 2.7% | 4.6% | 10.2% |
| ROCE % | - | 25.2% | 11.3% | 12.6% | 15.6% | 15.6% | 16.1% | 3.2% | 1.4% | - | 1.3% | 4.2% | 6.2% | 10.2% |
Shareholding Pattern
Insiders
2.16%
Institutions
107.09%
Public Float
109.45%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 12.56% | 10.53M | $926.75M |
| 2 | Wasatch Advisors LP | 8.59% | 7.20M | $633.79M |
| 3 | Vanguard Portfolio Management LLC | 4.97% | 4.16M | $366.35M |
| 4 | Vanguard Capital Management LLC | 4.56% | 3.82M | $336.46M |
| 5 | State Street Corporation | 3.70% | 3.10M | $272.76M |
| 6 | Morgan Stanley | 2.97% | 2.49M | $218.74M |
| 7 | Geode Capital Management, LLC | 2.70% | 2.26M | $198.83M |
| 8 | AQR Capital Management, LLC | 2.50% | 2.09M | $184.09M |
| 9 | William Blair Investment Management, LLC | 1.98% | 1.66M | $146.03M |
| 10 | Dimensional Fund Advisors LP | 1.94% | 1.63M | $143.16M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HQY
No recent headlines available.